Effects of Microtubule and Actin Inhibitors on Cryptococcus neoformans Examined by Scanning and Transmission Electron Microscopy
Language English Country Switzerland Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
25720843
DOI
10.1159/000371413
PII: 000371413
Knihovny.cz E-resources
- MeSH
- Actins antagonists & inhibitors ultrastructure MeSH
- Benzimidazoles pharmacology MeSH
- Bridged Bicyclo Compounds, Heterocyclic pharmacology MeSH
- Cryptococcus neoformans drug effects ultrastructure MeSH
- Carbamates pharmacology MeSH
- Humans MeSH
- Microscopy, Electron, Scanning methods MeSH
- Microtubules drug effects ultrastructure MeSH
- Thiazolidines pharmacology MeSH
- Microscopy, Electron, Transmission methods MeSH
- Vincristine pharmacology MeSH
- Treatment Outcome MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Actins MeSH
- Benzimidazoles MeSH
- Bridged Bicyclo Compounds, Heterocyclic MeSH
- carbendazim MeSH Browser
- Carbamates MeSH
- latrunculin A MeSH Browser
- Thiazolidines MeSH
- Vincristine MeSH
BACKGROUND: Cryptococcus neoformans is one of the most important human fungal pathogens. Its cells contain rich microtubules required for nuclear division and rich F-actin cytoskeletons for cell division. Disruption of microtubules by a microtubule inhibitor should block nuclear division, and disruption of F-actin by an actin inhibitor should block cell division. We investigated the effects of microtubule and actin inhibitors to find out whether the cytoskeletons of C. neoformans can become a new anti-fungal target for the inhibition of cell division, when examined at the ultrastructural level. METHODS: Cells treated with the microtubule inhibitors vincristine (VIN) and methyl benzimidazole-2-ylcarbamate (BCM) and the actin inhibitor latrunculin A (LA), in yeast extract peptone dextrose medium, were examined by scanning (SEM) and transmission electron microscopy (TEM), and the cell number was counted using a Bürker chamber. RESULTS: After 2 days of inhibition with VIN, BCM or LA, the cells did not divide, but later, resistant, proliferating cells appeared in all samples. With combined microtubule and actin inhibitors (VIN + LA or BCM + LA), cells did not divide during 6 or even 14 days, and no resistant cells originated. TEM showed that the inhibited cells were without cytoplasm and were dead; only empty cell walls persisted with reduced capsules, shown on SEM. CONCLUSION: Combined microtubule and actin inhibitors (VIN + LA or BCM + LA), have lethal effects on C. neoformans cells and no resistant cells originate.
References provided by Crossref.org